Nexentis Technologies Inc. (NXTS) News
Track canonical SquawkNews coverage tagged to NXTS, Nexentis Technologies Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 13 indexed stories across 5 publication days and is ordered by the same first-publication timeline used by LiveCast.
H
Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
Leading computational chemistry expert to advise MitoCareX as it expands its in silico drug-discovery capabilitiesNess Ziona, Israel, Sept. 24, 2026 (GLOBE NEWSWIRE) -- Nexentis Technologies Inc. (“Nexentis”), NASDAQ:NXT
GEOPOLITICS | Sep 24, 2026, 11:51 AM UTC
L
NXTS - Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
NXTS - Nexentis: MitoCareX Strengthens Its Computational Drug Discovery Capabilities with Appointment of Prof. Dan T. Major to Scientific Advisory Board
NEWS | Sep 24, 2026, 11:50 AM UTC
H
Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
Evaluation of additional commercially available approaches for obtaining proteins is intended to enhance access to research materials, increase research flexibility and support the advancement of MitoCareX’s future in-vi
GEOPOLITICS | Sep 23, 2026, 11:11 AM UTC
L
NXTS - Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
NXTS - Nexentis: MitoCareX Evaluates Expanded Protein Capabilities to Enhance Flexibility and Support Future Drug Discovery
NEWS | Sep 23, 2026, 11:07 AM UTC
M
Nexentis received Nasdaq notice over continued listing equity shortfall
Nasdaq notified Nexentis that it no longer meets Listing Rule 5550(b)(1) requiring at least $2.5 million in stockholders’ equity. The company reported $1,782,000 as of June 30, 2026 and has until October 15, 2026 to subm
EQUITY | Sep 03, 2026, 08:35 PM UTC
H
Oil Down 1%
Crude oil prices fall over 1% as US manufacturing PMI surges in June
COMMODITIES | Jun 23, 2026, 04:42 PM UTC
H
Small Caps Plummet
Multiple small cap stocks are experiencing significant premarket declines due to various negative news and filings
EQUITY | Jun 23, 2026, 01:13 PM UTC
H
NXTS Plunges 48%
NXTS leads small cap negative movers premarket, down 48% on momentum, followed by WHLR, KIDZ, and others
EQUITY | Jun 23, 2026, 12:22 PM UTC
L
RDGT Leads Premarket Gainers
RDGT leads premarket upside movers, while NXTS leads downside movers
EQUITY | Jun 23, 2026, 10:52 AM UTC
M
RDGT Leads Premarket Gainers
RDGT leads premarket gainers, followed by GITS, CIIT, and ADTX, while NXTS leads decliners
EQUITY | Jun 23, 2026, 09:32 AM UTC
H
NXTS Soars 156%
Nexentis Technologies' stock soars 156% before falling 46% after hours
EQUITY | Jun 23, 2026, 05:51 AM UTC
H
GETY +125% on OpenAI Deal
GETY surges 125% on display partnership with OpenAI, leading small cap gainers in premarket trading
EQUITY | Jun 22, 2026, 01:17 PM UTC
M
NXTS Launches AI Drug Initiative
Nexentis Technologies announces international AI drug discovery initiative with MitoCareX Bio and Boltz to accelerate novel SLC small-molecule discovery
EQUITY | Jun 22, 2026, 12:22 PM UTC